Nutraceutical Business Review: The MPS II and macular screening

What does a larger and more aged population mean for our approach to eye health? This is the question posed by the Nutraceutical Business Review, who recently published our paper on MPS II and macular screening.

A condensed-version of our popular whitepaper is available to read and share on their website.

The article covers the full impact of AMD now and in the future, AMD risk factors, an in-depth look at macular pigment optical density and the role of supplementation.

f_44579Read the article on Nutraceutical Business Review or download the full paper from our website.

Leave a Reply

Your email address will not be published. Required fields are marked *